Inhibiting BRAF/EGFR/MEK Suppresses Cancer Stemness and Drug Resistance of Primary Colorectal Cancer Cells

Researchers developed spheroid cultures of patient-derived BRAFmut and KRASmut tumor cells and studied resistance mechanisms to inhibition of MAPK pathway through phenotypic and gene and protein expression analysis.